+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Increased QT variability in young asymptomatic patients with beta-thalassemia major

Increased QT variability in young asymptomatic patients with beta-thalassemia major

European Journal of Haematology 79(4): 322-329

Despite recent progress in iron chelation therapy, sudden cardiac death due to malignant ventricular arrhythmias remains a vexing, clinical problem in patients with beta-thalassemia major (TM). In this study we assessed whether the major indices of QT variability, emerging tools for risk stratification of sudden cardiac death, differ in young asymptomatic patients with TM and healthy persons. Thirty patients with TM and 30 healthy control subjects underwent a 5-min electrocardiography recording to calculate the following variables: QT variance (QT(v)), QT(v) normalized for mean QT (QTVN) and QT variability index (QTVI). All subjects also underwent a two-dimensional and Doppler echocardiography study and magnetic resonance imaging (MRI) to determine cardiac and hepatic T2* values. No differences were observed in clinical and conventional echo-Doppler findings in healthy control subjects and patients with TM whereas QT(v), QTVN and QTVI values were significantly higher in patients than those in controls (QT(v), P < 0.001; QTVN, P < 0.05 and QTVI, P < 0.001) and cardiac T2* and hepatic MRI T2* values were significantly lower in patients with TM (P < 0.001). The indices of temporal QT variability correlated significantly with MRI data. Young asymptomatic patients with TM have increased cardiac repolarization variability as assessed by QT variability indices, probably due to cardiac iron deposition. These easily assessed, non-invasive markers could be used to identify increased myocardial repolarization lability early in asymptomatic patients with TM.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 053799249

Download citation: RISBibTeXText

PMID: 17655692

DOI: 10.1111/j.1600-0609.2007.00921.x

Related references

A comparison of heart function and arrhythmia in clinically asymptomatic patients with beta thalassemia intermedia and beta thalassemia major. Hematology 22(1): 25-29, 2016

Echocardiographic evaluation of asymptomatic young patients with thalassemia major. European Heart Journal 9(ABSTR SUPPL 1): 21, 1988

Echocardiographic assessment of asymptomatic young patients with thalassemia major. Cardiologia 34(3): 221-227, 1989

Prognostic value of the Atrial Natriuretic Peptide in asymptomatic patients with beta-thalassemia major Ten-year follow-up. European Journal Of Clinical Investigation. 29(suppl. 1): 65, Il, 1999

Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood 107(9): 3738-3744, 2005

Association of high body iron stores to asymptomatic carotid atherosclerosis in beta-thalassemia major patients. European Heart Journal 18(ABSTR SUPPL ): 337, 1997

Investigation of variability in response to deferiprone in patients with beta-thalassemia major. Clinical Pharmacology & Therapeutics 61(2): 146, 1997

Subclinical atherosclerosis in young beta-thalassemia major patients. Hemoglobin 33(6): 463-474, 2010

The Diagnostic Value of Pulsed Wave Tissue Doppler Imaging in Asymptomatic Beta- Thalassemia Major Children and Young Adults; Relation to Chemical Biomarkers of Left Ventricular Function and Iron Overload. Mediterranean Journal of Hematology and Infectious Diseases 7(1): E2015051, 2015

Early impairment of myocardial function in young patients with beta-thalassemia major. European Journal of Haematology 80(6): 515-522, 2008

Diastolic function in young patients with beta-thalassemia major: an echocardiographic study. Echocardiography 23(1): 38-44, 2006

Endothelial function and inflammatory process in young patients with beta-thalassemia major. Journal of the American College of Cardiology 41(6 Supplement A): 268A, March 19, 2003

Oxygen free radical-dependent increased platelet function in beta-thalassemia major patients. Thrombosis Research 92(6): 283-286, 1998

Comparative study of radiographic and laboratory findings between Beta thalassemia major and Beta thalassemia intermedia patients with and without treatment by hydroxyurea. Iranian Red Crescent Medical Journal 17(2): E23607, 2015

Molecular characterization of beta globin gene mutations in malay patients with hb e beta thalassemia and thalassemia major. British Journal of Haematology 72(1): 73-80, 1989